Low-Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease

被引:1
|
作者
Zuarth-Vazquez, Julia [1 ]
Moreno-Castaneda, Lidia [1 ]
Soriano-Marquez, Juan Pablo [2 ]
Velazquez-Aleman, Alain [3 ]
Ramos-Ostos, Martha Helena [4 ]
Uribe, Misael [2 ]
Lopez-Mendez, Ivan [5 ]
Juarez-Hernandez, Eva [3 ]
机构
[1] Med Clin & Fdn, Internal Med Dept, Mexico City 14050, Mexico
[2] Med Clin & Fdn, Gastroenterol & Obes Unit, Mexico City 14050, Mexico
[3] Med Clin & Fdn, Translat Res Unit, Mexico City 14050, Mexico
[4] Med Clin & Fdn, Integral Diag & Treatment Ctr, Mexico City 14050, Mexico
[5] Med Clin & Fdn, Hepatol & Transplants Unit, Mexico City 14050, Mexico
来源
LIFE-BASEL | 2023年 / 13卷 / 04期
关键词
thyroid function; steatosis; metabolic syndrome; controlled attenuation parameter; GLOBAL EPIDEMIOLOGY; RISK; TSH;
D O I
10.3390/life13041048
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The association of low-normal thyroid function (LNTF) with non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated fatty liver disease (MAFLD) is controversial; thus, the aim of this study is to determine this association. Methods: NAFLD was evaluated by controlled attenuation parameter of transient elastography. Patients were classified by MAFLD criteria. LNTF was defined as TSH levels of 2.5 to 4.5 mIU/L and were divided into three different cut-off points (>4.5 to 5.0, >3.1, and >2.5 mIU/L). Associations between LNTF, NAFLD, and MAFLD were evaluated by univariate and multivariate logistic regression analyses. Results: A total of 3697 patients were included; 59% (n = 2179) were male, and median age and body mass index were 48 (43-55) years and 25.9 (23.6-28.5) kg/m(2), respectively, and 44% (n = 1632) were diagnosed with NAFLD. THS levels of 2.5 and 3.1 showed significant associations with the presence of NAFLD and MAFLD; however, LNTF did not show an independent association with the presence of NAFLD or MAFLD in multivariate analysis. According to different cut-off points, patients with LNTF presented similar risks for NAFLD as the general population. Conclusion: LNTF is not associated with NAFLD or MAFLD. Patients with high LNTF are equally at risk for NAFLD as the general population.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IS ASSOCIATED WITH SUBCLINICAL ATHEROSCLEROSIS MORE THAN NON-ALCOHOLIC FATTY LIVER DISEASE
    Park, Jung Gil
    Jang, Jaeyoung
    Lee, Yu Rim
    Kang, Min Kyu
    Jang, Se Young
    Kweon, Young-Oh
    Tak, Won Young
    Park, Soo Young
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1212 - S1212
  • [2] Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
    Jung, Han Na
    Jung, Chang Hee
    [J]. DIABETES & METABOLISM JOURNAL, 2023, 47 (02) : 198 - 200
  • [3] Non-alcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: Conceptual changes for clinicians, researchers and patients
    Lin, Shuang Zhe
    Chen, Yuan Wen
    Fan, Jian Gao
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2020, 21 (11) : 604 - 609
  • [4] Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease
    Colaci, Carmen
    Gambardella, Maria Luisa
    Scarlata, Giuseppe Guido Maria
    Boccuto, Luigi
    Colica, Carmela
    Luzza, Francesco
    Scarpellini, Emidio
    Mendez-Sanchez, Nahum
    Abenavoli, Ludovico
    [J]. HEPATOMA RESEARCH, 2024, 10
  • [5] Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease
    Tatsuki Uehara
    Hiromichi Wakui
    Kouichi Tamura
    [J]. Hypertension Research, 2023, 46 : 1165 - 1167
  • [6] Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease
    Uehara, Tatsuki
    Wakui, Hiromichi
    Tamura, Kouichi
    [J]. HYPERTENSION RESEARCH, 2023, 46 (05) : 1165 - 1167
  • [8] Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
    Song, Byeong Geun
    Kang, Tae Wook
    Sinn, Dong Hyun
    Kim, Yeun-Yoon
    Min, Ji Hye
    Hwang, Jeong Ah.
    Shin, Jaeseung
    [J]. CLINICAL IMAGING, 2024, 108
  • [9] Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis
    Virk, Ghazala S.
    Vajje, Jaahnavi
    Virk, Nausheen K.
    Mannam, Raam
    Rehman, Wajeeh
    Ghobriel, Naglaa G.
    Mian, Irfan-ud-din
    Usama, Muhammad
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [10] Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes?
    Kaya, Eda
    Zedginidze, Aleko
    Bechmann, Lars
    Canbay, Ali
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2022, 11 (02) : 299 - 301